During 2007, Pharmasav  was appointed as the UK agent for PollenAid by Graminex, a company based in United States of America.

Clinical evidence demonstrates the health benefits of PollenAid and further details can be found on the www.graminex.com website.

Health claims to support PollenAid’s use in the maintenance of normal urinary function and prostate health have been included in the UK’s Article 13 candidate list submitted to the EFSA in July 2008, following review by the European Commission.